Skip to main content

Clinical and Laboratory Diagnosis of Peroxisomal Disorders

  • Protocol
  • First Online:
Peroxisomes

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1595))

Abstract

The peroxisomal disorders (PDs) are a heterogeneous group of genetic diseases in man caused by an impairment in peroxisome biogenesis or one of the metabolic functions of peroxisomes. Thanks to the revolutionary technical developments in gene sequencing methods and their increased use in patient diagnosis, the field of genetic diseases in general and peroxisomal disorders in particular has dramatically changed in the last few years. Indeed, several novel peroxisomal disorders have been identified recently and in addition it has been realized that the phenotypic spectrum of patients affected by a PD keeps widening, which makes clinical recognition of peroxisomal patients increasingly difficult. Here, we describe these new developments and provide guidelines for the clinical and laboratory diagnosis of peroxisomal patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferdinandusse S, Jimenez-Sanchez G, Koster J, Denis S, Van Roermund CW, Silva-Zolezzi I, Moser AB, Visser WF, Gulluoglu M, Durmaz O, Demirkol M, Waterham HR, Gokcay G, Wanders RJ, Valle D (2015) A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3. Hum Mol Genet 24:361–370

    Article  CAS  PubMed  Google Scholar 

  2. Buchert R, Tawamie H, Smith C, Uebe S, Innes AM, Al Hallak B, Ekici AB, Sticht H, Schwarze B, Lamont RE, Parboosingh JS, Bernier FP, Abou Jamra R (2014) A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency. Am J Hum Genet 95:602–610

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Baroy T, Koster J, Stromme P, Ebberink MS, Misceo D, Ferdinandusse S, Holmgren A, Hughes T, Merckoll E, Westvik J, Woldseth B, Walter J, Wood N, Tvedt B, Stadskleiv K, Wanders RJ, Waterham HR, Frengen E (2015) A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform. Hum Mol Genet 24:5845–5854

    Article  PubMed  Google Scholar 

  4. Sevin C, Ferdinandusse S, Waterham HR, Wanders RJA, Aubourg P (2011) Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene. Orphanet J Rare Dis 6:8

    Article  PubMed  PubMed Central  Google Scholar 

  5. Regal L, Ebberink MS, Goemans N, Wanders RJA, De ML, Jaeken J, Schrooten M, Van CR, Waterham HR (2010) Mutations in PEX10 are a cause of autosomal recessive ataxia. Ann Neurol 68:259–263

    CAS  PubMed  Google Scholar 

  6. Ratbi I, Falkenberg KD, Sommen M, Al-Sheqaih N, Guaoua S, Vandeweyer G, Urquhart JE, Chandler KE, Williams SG, Roberts NA, El Alloussi M, Black GC, Ferdinandusse S, Ramdi H, Heimler A, Fryer A, Lynch SA, Cooper N, Ong KR, Smith CE, Inglehearn CF, Mighell AJ, Elcock C, Poulter JA, Tischkowitz M, Davies SJ, Sefiani A, Mironov AA, Newman WG, Waterham HR, Van Camp G (2015) Heimler syndrome is caused by hypomorphic mutations in the peroxisome-biogenesis genes PEX1 and PEX6. Am J Hum Genet 97:535–545

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Bowen P, Lee CSM, Zellweger H, Lindenberg R (1964) A familial syndrome of multiple congenital defects. Bull Johns Hopkins Hosp 114:402–414

    CAS  PubMed  Google Scholar 

  8. Brown FR, McAdams AJ, Cummins JW, Konkol R, Singh I, Moser AB, Moser HW (1982) Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids. Johns Hopkins Med J 151:344–351

    PubMed  Google Scholar 

  9. Heymans HSA, Schutgens RBH, Tan R, van den Bosch H, Borst P (1983) Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome). Nature 306:69–70

    Article  CAS  PubMed  Google Scholar 

  10. Klouwer FC, Huffnagel IC, Ferdinandusse S, Waterham HR, Wanders RJ, Engelen M, Poll-The BT (2016) Clinical and biochemical pitfalls in the diagnosis of peroxisomal disorders. Neuropediatrics 47(4):205–220

    Article  CAS  PubMed  Google Scholar 

  11. Ferdinandusse S, Denis S, Mooyer PA, Dekker C, Duran M, Soorani-Lunsing RJ, Boltshauser E, Macaya A, Gartner J, Majoie CB, Barth PG, Wanders RJA, Poll-The BT (2006) Clinical and biochemical spectrum of D-bifunctional protein deficiency. Ann Neurol 59:92–104

    Article  PubMed  Google Scholar 

  12. Ferdinandusse S, Denis S, Hogenhout EM, Koster J, van Roermund CWT, IJlst L, Moser AB, Wanders RJA, Waterham HR (2007) Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency. Hum Mutat 28:904–912

    Article  CAS  PubMed  Google Scholar 

  13. Goldfischer S, Collins J, Rapin I, Neumann P, Neglia W, Spiro AJ, Ishii T, Roels F, Vamecq J, Van Hoof F (1986) Pseudo-Zellweger syndrome: deficiencies in several peroxisomal oxidative activities. J Pediatr 108:25–32

    Article  CAS  PubMed  Google Scholar 

  14. Ferdinandusse S, Barker S, Lachlan K, Duran M, Waterham HR, Wanders RJA, Hammans S (2010) Adult peroxisomal acyl-coenzyme A oxidase deficiency with cerebellar and brainstem atrophy. J Neurol Neurosurg Psychiatry 81:310–312

    Article  PubMed  Google Scholar 

  15. Pierce SB, Walsh T, Chisholm KM, Lee MK, Thornton AM, Fiumara A, Opitz JM, Levy-Lahad E, Klevit RE, King MC (2010) Mutations in the DBP-deficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault Syndrome. Am J Hum Genet 87:282–288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. McMillan HJ, Worthylake T, Schwartzentruber J, Gottlieb CC, Lawrence SE, Mackenzie A, Beaulieu CL, Mooyer PA, Wanders RJA, Majewski J, Bulman DE, Geraghty MT, Ferdinandusse S, Boycott KM (2012) Specific combination of compound heterozygous mutations in 17beta-hydroxysteroid dehydrogenase type 4 (HSD17B4) defines a new subtype of D-bifunctional protein deficiency. Orphanet J Rare Dis 7:1–9

    Article  Google Scholar 

  17. Mizumoto H, Akashi R, Hikita N, Kumakura A, Yoshida Y, Honda A, Shimozawa N, Hata D (2012) Mild case of D-bifunctional protein deficiency associated with novel gene mutations. Pediatr Int 54:303–304

    Article  PubMed  Google Scholar 

  18. Lines MA, Jobling R, Brady L, Marshall CR, Scherer SW, Rodriguez AR, Lee L, Lang AE, Mestre TA, Wanders RJ, Ferdinandusse S, Tarnopolsky MA, Canadian Pediatric Genetic Disorders Sequencing Consortium (2014) Peroxisomal D-bifunctional protein deficiency: three adults diagnosed by whole-exome sequencing. Neurology 82:963–968

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ferdinandusse S, Ebberink MS, Vaz FM, Waterham HR, Wanders RJ (2016) The important role of biochemical and functional studies in the diagnostics of peroxisomal disorders. J Inherit Metab Dis 39:531–543

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Bams-Mengerink AM, Majoie CB, Duran M, Wanders RJA, Van HJ, Scheurer CD, Barth PG, Poll-The BT (2006) MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata. Neurology 66:798–803

    Article  CAS  PubMed  Google Scholar 

  21. Bams-Mengerink AM, Koelman JH, Waterham H, Barth PG, Poll-The BT (2013) The neurology of rhizomelic chondrodysplasia punctata. Orphanet J Rare Dis 8:174

    Article  PubMed  PubMed Central  Google Scholar 

  22. Smeitink JA, Beemer FA, Espeel M, Donckerwolcke RA, Jakobs C, Wanders RJA, Schutgens RBH, Roels F, Duran M, Dorland L et al (1992) Bone dysplasia associated with phytanic acid accumulation and deficient plasmalogen synthesis: a peroxisomal entity amenable to plasmapheresis. J Inherit Metab Dis 15:377–380

    Article  CAS  PubMed  Google Scholar 

  23. Engelen M, Kemp S, de Visser M, van Geel BM, Wanders RJA, Aubourg PA, Poll-The BT (2012) X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis 7:51

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kemp S, Huffnagel IC, Linthorst GE, Wanders RJ, Engelen M (2016) Adrenoleukodystrophy—neuroendocrine pathogenesis and redefinition of natural history. Nat Rev Endocrinol 12(10):606–615

    Article  CAS  PubMed  Google Scholar 

  25. Guimaraes CP, Domingues P, Aubourg P, Fouquet F, Pujol A, Jimenez-Sanchez G, Sa-Miranda C, Azevedo JE (2004) Mouse liver PMP70 and ALDP: homomeric interactions prevail in vivo. Biochim Biophys Acta 1689:235–243

    Article  CAS  PubMed  Google Scholar 

  26. Wiesinger C, Kunze M, Regelsberger G, Forss-Petter S, Berger J (2013) Impaired very long-chain acyl-CoA beta-oxidation in human X-ALD fibroblasts is a direct consequence of ABCD1 transporter dysfunction. J Biol Chem 288:19269–19279

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Theda C, Woody RC, Naidu S, Moser AB, Moser HW (1993) Increased very long chain fatty acids in patients on a ketogenic diet: a cause of diagnostic confusion. J Pediatr 122:724–726

    Article  CAS  PubMed  Google Scholar 

  28. Lam C, Wong D, Cederbaum S, Lim B, Qu Y (2012) Peanut consumption increases levels of plasma very long chain fatty acids in humans. Mol Genet Metab 107:620–622

    Article  CAS  PubMed  Google Scholar 

  29. Theda C, Gibbons K, Defor TE, Donohue PK, Golden WC, Kline AD, Gulamali-Majid F, Panny SR, Hubbard WC, Jones RO, Liu AK, Moser AB, Raymond GV (2014) Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible. Mol Genet Metab 111:55–57

    Article  CAS  PubMed  Google Scholar 

  30. Clarke CE, Alger S, Preece MA, Burdon MA, Chavda S, Denis S, Ferdinandusse S, Wanders RJA (2004) Tremor and deep white matter changes in alpha-methylacyl-CoA racemase deficiency. Neurology 63:188–189

    Article  CAS  PubMed  Google Scholar 

  31. Thompson SA, Calvin J, Hogg S, Ferdinandusse S, Wanders RJA, Barker RA (2008) Relapsing encephalopathy in a patient with alpha-methylacyl-CoA racemase deficiency. J Neurol Neurosurg Psychiatry 79:448–450

    Article  CAS  PubMed  Google Scholar 

  32. Kapina V, Sedel F, Truffert A, Horvath J, Wanders RJA, Waterham HR, Picard F (2010) Relapsing rhabdomyolysis due to peroxisomal alpha-methylacyl-CoA racemase deficiency. Neurology 75:1300–1302

    Article  CAS  PubMed  Google Scholar 

  33. Haugarvoll K, Johansson S, Tzoulis C, Haukanes BI, Bredrup C, Neckelmann G, Boman H, Knappskog PM, Bindoff LA (2013) MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing. Orphanet J Rare Dis 8:1–10

    Article  PubMed  PubMed Central  Google Scholar 

  34. Ferdinandusse S, Kostopoulos P, Denis S, Rusch H, Overmars H, Dillmann U, Reith W, Haas D, Wanders RJA, Duran M, Marziniak M (2006) Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy. Am J Hum Genet 78:1046–1052

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Horvath R, Lewis-Smith D, Douroudis K, Duff J, Keogh M, Pyle A, Fletcher N, Chinnery PF (2015) SCP2 mutations and neurodegeneration with brain iron accumulation. Neurology 85:1909–1911

    Article  PubMed  PubMed Central  Google Scholar 

  36. Jansen GA, Wanders RJA, Watkins PA, Mihalik SJ (1997) Phytanoyl-coenzyme A hydroxylase deficiency—the enzyme defect in Refsum's disease. N Engl J Med 337:133–134

    Article  CAS  PubMed  Google Scholar 

  37. Wierzbicki AS, Lloyd MD, Schofield CJ, Feher MD, Gibberd FB (2002) Refsum’s disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation. J Neurochem 80:727–735

    Article  CAS  PubMed  Google Scholar 

  38. Wanders RJA, Jakobs C, Skjeldal OH (2001) Refsum disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic & molecular bases of inherited disease, 8th edn. Mc Graw-Hill, New York, pp 3303–3321

    Google Scholar 

  39. Wanders RJA, Waterham HR, Leroy B (2006) Refsum disease. Gene Rev (www.genetests.org)

  40. van den Brink DM, Brites P, Haasjes J, Wierzbicki AS, Mitchell J, Lambert-Hamill M, de Belleroche J, Jansen GA, Waterham HR, Wanders RJA (2003) Identification of PEX7 as the second gene involved in refsum disease. Am J Hum Genet 72:471–477

    Article  PubMed  PubMed Central  Google Scholar 

  41. Salido E, Pey AL, Rodriguez R, Lorenzo V (2012) Primary hyperoxalurias: disorders of glyoxylate detoxification. Biochim Biophys Acta 1822:1453–1464

    Article  CAS  PubMed  Google Scholar 

  42. Koehler K, Malik M, Mahmood S, Giesselmann S, Beetz C, Hennings JC, Huebner AK, Grahn A, Reunert J, Nurnberg G, Thiele H, Altmuller J, Nurnberg P, Mumtaz R, Babovic-Vuksanovic D, Basel-Vanagaite L, Borck G, Bramswig J, Muhlenberg R, Sarda P, Sikiric A, Anyane-Yeboa K, Zeharia A, Ahmad A, Coubes C, Wada Y, Marquardt T, Vanderschaeghe D, Van Schaftingen E, Kurth I, Huebner A, Hubner CA (2013) Mutations in GMPPA cause a glycosylation disorder characterized by intellectual disability and autonomic dysfunction. Am J Hum Genet 93:727–734

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Bove KE, Daugherty CC, Tyson W, Mierau G, Heubi JE, Balistreri WF, Setchell KD (2000) Bile acid synthetic defects and liver disease. Pediatr Dev Pathol 3:1–16

    Article  CAS  PubMed  Google Scholar 

  44. Carlton VE, Harris BZ, Puffenberger EG, Batta AK, Knisely AS, Robinson DL, Strauss KA, Shneider BL, Lim WA, Salen G, Morton DH, Bull LN (2003) Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT. Nat Genet 34:91–96

    Article  CAS  PubMed  Google Scholar 

  45. Heubi JE, Setchell KD, Bove KE (2007) Inborn errors of bile acid metabolism. Semin Liver Dis 27:282–294

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

H. Waterham acknowledges support from the Marie Curie Initial Training Network (ITN) action (FP7-2012-PERFUME-316723).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ronald J. A. Wanders .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Wanders, R.J.A., Klouwer, F.C.C., Ferdinandusse, S., Waterham, H.R., Poll-Thé, B.T. (2017). Clinical and Laboratory Diagnosis of Peroxisomal Disorders. In: Schrader, M. (eds) Peroxisomes. Methods in Molecular Biology, vol 1595. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6937-1_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6937-1_30

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-6935-7

  • Online ISBN: 978-1-4939-6937-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics